ASTRO Presents First Guideline for RT in Pancreatic Cancer

Rachel Narozniak, MA
Published: Saturday, Nov 30, 2019
Albert C. Koong, MD, PhD, cochair of the RT task force and chair of the Department of Radiation Oncology at The University of Texas MD Anderson Cancer Center

Albert C. Koong, MD, PhD

Recent strides in systemic treatment approaches and the broader application of stereotactic radiation led the American Society for Radiation Oncology (ASTRO) to issue its first guideline regarding radiation therapy (RT) in patients with pancreatic cancer, a setting in which appropriate use of RT has been largely undefined.1

Koong and Palta agreed that outmoded and conflicting clinical trial data contribute to the lack of clarity surrounding RT. “Many of the trials that have focused on the question of RT versus no RT are pretty antiquated in terms of technique,” Palta said. “Since the trials that were done in the 1970s and 1980s, there really hasn’t been a trial that has evaluated RT in pancreatic cancer.”

Table 1. Key Trial Data Awaited in Pancreatic Cancer1,3

Table 1. Key Trial Data Awaited in Pancreatic Cancer Indications for Conventionally Fractionated RT or SBRT

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication